世界の骨移植・代替物市場2021-2028:材料タイプ別(同種移植、人工)、用途別(頭蓋顎顔面、歯、足・足首)、地域別

◆英語タイトル:Bone Graft And Substitutes Market Size, Share & Trends Analysis Report By Material Type (Allograft, Synthetic), By Application (Craniomaxillofacial, Dental, Foot & Ankle), By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MC008
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年2月26日
◆ページ数:145
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥684,250見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥799,250見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,029,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の骨移植・代替物市場規模が2028年までに43億ドルに達すると予測しています。2021年から2028年までに年平均5.8%成長する見通しです。本調査レポートでは、骨移植・代替物の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争分析、材料タイプ別(同種移植、人工)分析、用途別(頭蓋顎顔面、歯、足・足首、関節再建、長骨)分析、地域別分析、新型コロナウイルス感染症の影響分析、企業情報などを掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・競争分析
・骨移植・代替物の世界市場規模:材料タイプ別(同種移植、人工)
・骨移植・代替物の世界市場規模:用途別(頭蓋顎顔面、歯、足・足首、関節再建、長骨)
・骨移植・代替物の世界市場規模:地域別
・新型コロナウイルス感染症の影響分析
・企業情報
【レポートの概要】

Bone Graft And Substitutes Market Growth & Trends

The global bone graft and substitutes market size is expected to reach USD 4.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.8% from 2021 to 2028. The synthetic segment is anticipated to show significant growth over the forecast period. This growth is due to the lesser risk of disease transmission, better acceptance among patients as compared to allografts, and products’ better biocompatibility. However, the demand for orthopedic devices, which include bone graft and substitutes observed a radical decrease because of the rescheduling of elective surgeries during COVID-19.

Growing cases of spinal deformities are the key driver of this market. According to a CDC report, approximately 60.0% of the aged population and 32.0% of the adult population is suffering from spinal deformities, in the U.S., as of 2017. Around 488,000 spinal procedures were performed in the U.S. Moreover, the introduction of biocompatible synthetic grafts is also expected to drive the market.

Additionally, technological advancements and the growing geriatric population are also boosting the market growth. According to Population Reference Bureau’s 2018 statistics, from 13 countries to around 82 countries across the globe are expected to have more than 20% of the geriatric population (65 years and above) by 2050. Thus, perpetual growth in the population aged 60 years and above is anticipated to result in an increased prevalence of arthritis and joint disorders.

The market in various countries is expected to witness diverse trends because of ethical issues in some of the Muslim and Jewish population dominated countries. These countries include majorly the Middle Eastern countries, which are apprehensive about using xenografts for their orthopedic surgeries. Such factors hamper market growth drastically.

Key players in the market are investing in the launch of new products and product approvals for sustaining in the market. For instance, AlloSource stated that ProChondrix CR would have 2 years of shelf life based on the results of real-time testing, as of March 2019. ProChondrix CR helps in cartilage healing and is intended to match biochemical and biomechanical properties of normal hyaline cartilage, improve patient symptoms, and restore a smooth articular cartilage surface.

Bone Graft And Substitutes Market Report Highlights

• The allograft segment dominated the market in terms of revenue share as of 2020 and is projected to witness a CAGR of over 4.8% from 2021 to 2028. Adoption of allografts is rising due to their characteristics such as osteoconductivity and immediate structural support.

• North America held a major market share as of 2020, due to the growing awareness related to the commercially available advanced products, higher healthcare expenditure of 16.4% in 2018, and accessibility of a well-developed healthcare structure

• The synthetic segment which includes ceramics, composites, polymers, and BMPs is expected to exhibit the fastest growth over the forecast period owing to its increasing adoption

• The spinal fusion segment held a considerable revenue share of about 60.5% in the market in 2020 owing to the rising geriatric population

• In North America, the U.S. is generating the maximum demand for bone grafts and substitutes because of the high prevalence of trauma-related injuries and orthopedic diseases

• The industry participants are focusing on product launch, partnership, and acquisitions to sustain the competition

• In Asia Pacific, the market is anticipated to witness lucrative growth of more than 7.5% owing to the rising medical tourism and favorable government initiatives

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North america
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Latin america
1.3.5.5 Data for primary interviews in Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Abbreviations
1.10 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Bone Grafts & Substitutes market Outlook, 2016 – 2028 (USD Million)
2.2 Bone Grafts & Substitutes Market Summary, 2020
Chapter 3 Bone Grafts & Substitutes Market Variables, Trends & Scope
3.1 Regulatory Framework
3.2 USFDA Consideration
3.2.1 Bone grafts & substitutes that found to be medically necessary
3.3 Reimbursement framework
3.3.1 CPT Coding
3.3.2 HCPCS Coding
3.3.3 Market driver analysis
3.3.3.1 Rising incidence of bone & joint disorders
3.3.3.2 Advent of biocompatible synthetic graft
3.3.3.3 Rising demand for dental bone grafts
3.3.3.4 Technological advancement
3.3.3.5 Rising geriatric population
3.3.4 Market restraint analysis
3.3.4.1 Stringent regulatory guidelines
3.3.4.2 Risk of disease transmission
3.3.4.3 High cost of bone grafts and substitutes
3.4 Bone Grafts & Substitutes Market Analysis Tools: Porters
3.5 PESTEL Analysis
Chapter 4 Bone Grafts & Substitutes Market: Competitive Analysis
4.1 Innovators
4.2 Key Company Market Share Analysis, 2020 (Estimated)
4.3 Market Leaders
4.4 Market Leaders by Product Segment
4.5 Major Deals & Strategic Alliances Analysis
4.5.1 Product launch
4.5.2 Acquisitions
4.5.3 Product Approval
4.5.4 Partnership & Collaborations
4.6 List of private companies
Chapter 5 Bone Grafts & Substitutes Market: Material Type Estimates & Trend Analysis
5.1 Material Type Market Share Analysis, 2020 & 2028
5.2 Material Type Dashboard
5.2.1 Allograft
5.2.1.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
5.2.1.2 Demineralized Bone Matrix (DBM)
5.2.1.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
5.2.1.3 Others
5.2.1.3.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
5.2.2 Synthetic
5.2.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
5.2.2.2 Ceramic
5.2.2.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
5.2.2.2.2 HAP
5.2.2.2.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
5.2.2.2.3 ß-TCP
5.2.2.2.3.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
5.2.2.2.4 αlpha-tricalcium phosphate (αlpha-TCP)
5.2.2.2.4.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
5.2.2.2.5 Bi-phasic calcium phosphates (BCP)
5.2.2.2.5.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
5.2.2.2.6 Others
5.2.2.2.6.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
5.2.2.3 Composite
5.2.2.3.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
5.2.2.4 Polymers
5.2.2.4.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
5.2.2.5 BMP
5.2.2.5.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
Chapter 6 Bone Grafts & Substitutes Market: Application Estimates & Trend Analysis
6.1 Application Market Share Analysis, 2020 & 2028
6.2 Application Dashboard
6.3 Craniomaxillofacial
6.3.1 Craniomaxillofacial market estimates and forecasts, 2016 – 2028 (USD Million)
6.4 Dental
6.4.1 Dental market estimates and forecasts, 2016 – 2028 (USD Million)
6.5 Foot & Ankle
6.5.1 Foot & Ankle market estimates and forecasts, 2016 – 2028 (USD Million)
6.6 Joint Reconstruction
6.6.1 Joint Reconstruction market estimates and forecasts, 2016 – 2028 (USD Million)
6.7 Long Bone
6.7.1 Long Bone market estimates and forecasts, 2016 – 2028 (USD Million)
6.8 Spinal Fusion
6.8.1 Spinal Fusion market estimates and forecasts, 2016 – 2028 (USD Million)
Chapter 7 Bone Grafts & Substitutes Market: COVID19 Impact Analysis
7.1 COVID19 Prevalence Analysis
7.2 Opportunity Analysis
Chapter 8 Bone Grafts & Substitutes Market: Regional Estimates & Trend Analysis, By, Material Type, & Application
8.1 Regional Market Snapshot
8.2 North America
8.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
8.2.2 U.S.
8.2.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
8.2.3 Canada
8.2.3.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
8.3 Europe
8.3.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
8.3.2 U.K.
8.3.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
8.3.3 Germany
8.3.3.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
8.3.4 France
8.3.4.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
8.3.5 Italy
8.3.5.1 Market, 2016 – 2028 (USD Million)
8.3.6 Spain
8.3.6.1 Market, 2016 – 2028 (USD Million)
8.4 Asia Pacific
8.4.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
8.4.2 China
8.4.2.1 Market, 2016 – 2028 (USD Million)
8.4.3 Japan
8.4.3.1 Market, 2016 – 2028 (USD Million)
8.4.4 India
8.4.4.1 Market, 2016 – 2028 (USD Million)
8.4.5 South Korea
8.4.5.1 Market, 2016 – 2028 (USD Million)
8.5 Latin America
8.5.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
8.5.2 Mexico
8.5.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
8.5.3 Brazil
8.5.3.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
8.6 MEA
8.6.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
8.6.2 South Africa
8.6.2.1 Market estimates and forecasts, 2016 – 2028 (USD Million)
Chapter 9 Company Profiles
9.1 AlloSource
9.1.1 Company overview
9.1.2 Financial Performance
9.1.3 Product benchmarking
9.1.4 Strategic Initiatives
9.2 Baxter
9.2.1 Company overview
9.2.2 Financial Performance
9.2.3 Product benchmarking
9.2.4 Strategic Initiatives
9.3 DePuy Synthes, Inc.
9.3.1 Company overview
9.3.2 Financial Performance
9.3.3 Product benchmarking
9.3.4 Strategic Initiatives
9.4 Medtronic
9.4.1 Company overview
9.4.2 Financial Performance
9.4.3 Product benchmarking
9.4.4 Strategic Initiatives
9.5 Nuvasive, Inc.
9.5.1 Company overview
9.5.2 Financial Performance
9.5.3 Product benchmarking
9.5.4 Strategic Initiatives
9.6 Orthofix Holdings, Inc.
9.6.1 Company overview
9.6.2 Financial Performance
9.6.3 Product benchmarking
9.6.4 Strategic Initiatives
9.7 Smith & Nephew, Inc.
9.7.1 Company overview
9.7.2 Financial Performance
9.7.3 Product benchmarking
9.7.4 Strategic Initiatives
9.8 Stryker Corporation
9.8.1 Company overview
9.8.2 Financial Performance
9.8.3 Product benchmarking
9.8.4 Strategic Initiatives
9.9 Wright Medical Group N.V.
9.9.1 Company overview
9.9.2 Financial Performance
9.9.3 Product benchmarking
9.9.4 Strategic Initiatives
9.10 OST Développement
9.10.1 Company overview
9.10.2 Financial Performance
9.10.3 Product benchmarking
9.11 Zimmer Biomet
9.11.1 Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.12 Geistlich Pharma AG
9.12.1 Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.13 TBF Tissue Engineering
9.13.1 Company overview
9.13.2 Product benchmarking
9.14 Biobank
9.14.1 Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking

List of Tables

TABLE 1 List of secondary sources
TABLE 2 Primary interview details: North America
TABLE 3 Primary interview details: Europe
TABLE 4 Primary interview details: APAC
TABLE 5 Primary interview details: Latin America
TABLE 6 Primary interview details: MEA
TABLE 7 List of abbreviation
TABLE 8 Average cost of bone graft (2019)
TABLE 9 North America Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 10 North America Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 11 U.S. Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 12 U.S. Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 13 Canada Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 14 Canada Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 15 Europe Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 16 Europe Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 17 U.K. Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 18 U.K. Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 19 Germany Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 20 Germany Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 21 France Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 22 France Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 23 Italy Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 24 Italy Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 25 Spain Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 26 Spain Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 27 Asia Pacific Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 28 Asia Pacific Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 29 Japan Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 30 Japan Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 31 China Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 32 China Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 33 India Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 34 India Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 35 South Korea Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 36 South Korea Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 37 Latin America Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 38 Latin America Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 39 Brazil Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 40 Brazil Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 41 Mexico Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 42 Mexico Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 43 MEA Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 44 MEA Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 45 South Africa Bone Graft & Substitutes market estimates and forecasts, by material type, 2016 - 2028 (USD Million)
TABLE 46 South Africa Bone Graft & Substitutes market estimates and forecasts, by application, 2016 - 2028 (USD Million)
TABLE 47 Major merger & acquisitions
TABLE 48 List of key emerging companies
TABLE 49 List of key private companies
TABLE 50 List of Distributors

List of Figures

FIG. 1 Market segmentation
FIG. 2 Market research process
FIG. 3 Data triangulation techniques
FIG. 4 Primary research pattern
FIG. 5 Primary interviews in North America
FIG. 6 Primary interviews in Europe
FIG. 7 Primary interviews in Asia Pacific
FIG. 8 Primary interviews in Latin America
FIG. 9 Primary interviews in Middle East and Africa
FIG. 10 Market research approaches
FIG. 11 Value-chain-based sizing & forecasting
FIG. 12 QFD modeling for market share assessment
FIG. 13 Market formulation & validation
FIG. 14 Commodity flow analysis
FIG. 15 BGS market, 2016-2028 (USD Millions)
FIG. 16 Bone Grafts & Substitutes market snapshot
FIG. 17 Bone Grafts & Substitutes market driver impact
FIG. 18 Common Causes of Spinal Injury, 2018
FIG. 19 Age Distribution of Spinal Fusion Surgeries,2018
FIG. 20 Bone grafts & Substitutes market restraint impact
FIG. 21 Bone grafts & substitutes market Porter’s five forces analysis
FIG. 22 Bone grafts & substitutes market PESTEL analysis
FIG. 23 Company market share analysis (Estimated)
FIG. 24 Market leader by product segment
FIG. 25 Strategy mapping
FIG. 26 Bone grafts & substitutes market: material type movement analysis
FIG. 27 Bone grafts & substitutes market material type dashboard
FIG. 28 Global allograft market, 2016 - 2028 (USD Million)
FIG. 29 Global demineralized bone matrix (DBM) market, 2016 - 2028 (USD Million)
FIG. 30 Global others market, 2016 - 2028 (USD Million)
FIG. 31 Global synthetic market, 2016 - 2028 (USD Million)
FIG. 32 Global Ceramic market, 2016 - 2028 (USD Million)
FIG. 33 Global HAP market, 2016 - 2028 (USD Million)
FIG. 34 Global ß-TCP market, 2016 - 2028 (USD Million)
FIG. 35 Global α-TCP market, 2016 - 2028 (USD Million)
FIG. 36 Global bi-phasic calcium phosphates (BCP) market, 2016 - 2028 (USD Million)
FIG. 37 Global others market, 2016 - 2028 (USD Million)
FIG. 38 Global composite market, 2016 - 2028 (USD Million)
FIG. 39 Global polymers market, 2016 - 2028 (USD Million)
FIG. 40 Global BMP market, 2016 - 2028 (USD Million)
FIG. 41 Bone Grafts & Substitutes market: Application movement analysis
FIG. 42 Bone Grafts & Substitutes Application dashboard
FIG. 43 Global craniomaxillofacial market, 2016 - 2028 (USD Million)
FIG. 44 Global dental market, 2016 - 2028 (USD Million)
FIG. 45 Global foot & ankle market, 2016 - 2028 (USD Million)
FIG. 46 Global joint reconstruction market, 2016 - 2028 (USD Million)
FIG. 47 Global long bone market, 2016 - 2028 (USD Million)
FIG. 48 Global spinal fusion market, 2016 - 2028 (USD Million)
FIG. 49 Regional market place: Key takeaways
FIG. 50 Regional outlook, 2020 & 2028
FIG. 51 North America bone grafts & substitutes market, 2016 - 2028 (USD Million)
FIG. 52 U.S. bone grafts & substitutes market, 2016 - 2028 (USD Million)
FIG. 53 Canada bone grafts & substitutes market, 2016 - 2028 (USD Million)
FIG. 54 Europe bone grafts & substitutes market, 2016 - 2028 (USD Million)
FIG. 55 U.K. bone grafts & substitutes market, 2016 - 2028 (USD Million)
FIG. 56 Germany bone grafts & substitutes market, 2016 - 2028 (USD Million)
FIG. 57 France bone grafts & substitutes market, 2016 - 2028 (USD Million)
FIG. 58 Italy bone graft and substitutes market, 2016 - 2028 (USD Million)
FIG. 59 Spain bone graft and substitutes market, 2016 - 2028 (USD Million)
FIG. 60 Asia Pacific bone grafts & substitutes market, 2016 - 2028 (USD Million)
FIG. 61 China bone graft and substitutes market, 2016 - 2028 (USD Million)
FIG. 62 Japan bone graft and substitutes market, 2016 - 2028 (USD Million)
FIG. 63 India bone graft and substitutes market, 2016 - 2028 (USD Million)
FIG. 64 South Korea bone graft and substitutes market, 2016 - 2028 (USD Million)
FIG. 65 Latin America bone grafts & substitutes market, 2016 - 2028 (USD Million)
FIG. 66 Mexico bone grafts & substitutes market, 2016 - 2028 (USD Million)
FIG. 67 Brazil bone grafts & substitutes market, 2016 - 2028 (USD Million)
FIG. 68 MEA bone grafts & substitutes market, 2016 - 2028 (USD Million)
FIG. 69 South Africa bone grafts & substitutes market, 2016 - 2028 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の骨移植・代替物市場2021-2028:材料タイプ別(同種移植、人工)、用途別(頭蓋顎顔面、歯、足・足首)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆